Name
Purdue University Globle
NU576 NP II – Primary Care of Women’s Health
Prof. Name
Date
Breast conditions range from common benign problems such as fibroadenomas, breast cysts, and mastitis to potentially serious conditions such as breast cancer. In clinical practice, the key to managing breast concerns is a systematic evaluation that combines the patient’s history, physical examination, appropriate imaging, and timely follow-up. Although most breast abnormalities are not cancerous, a new or changing breast mass, nipple abnormality, skin change, or other concerning finding should be evaluated promptly.
Advanced practice nurses, primary care providers, and other clinicians play an important role in recognizing abnormal breast findings, educating patients about screening and breast health, documenting clinical findings, and coordinating diagnostic or specialty care when necessary.
A comprehensive breast evaluation generally includes:
Detailed medical and breast history
Clinical breast examination when appropriate
Risk assessment for breast cancer
Diagnostic or screening imaging based on the clinical situation
Accurate documentation of abnormal findings
Appropriate follow-up, biopsy, or referral when indicated
The goal is not simply to identify breast cancer but also to distinguish common benign conditions from abnormalities that require additional investigation.
Understanding breast anatomy helps clinicians accurately describe and document breast findings. Breast tissue extends across several anatomical regions, including the upper outer portion of the breast and the axillary tail.
The upper outer quadrant has historically been reported as the most common location for breast cancer, partly because it contains a relatively large amount of breast tissue. However, breast cancer can develop in any quadrant or region of the breast.
During a clinical breast examination, providers should document the precise location and characteristics of any abnormality. Useful documentation includes:
Clock-face position or breast quadrant
Distance from the nipple
Size of the lesion
Shape and margins
Consistency
Mobility
Tenderness
Skin changes
Nipple changes
Associated lymph node findings
Consistent documentation makes it easier to compare findings during subsequent examinations and supports communication among healthcare professionals.
Breast screening and diagnostic evaluation serve different purposes. Screening mammography is used primarily for people without breast symptoms or known abnormalities, whereas diagnostic breast imaging is used to evaluate a concerning symptom or abnormal clinical or screening finding.
The appropriate evaluation depends on factors such as age, symptoms, breast density, personal and family history, genetic risk, and previous imaging results.
Screening mammography is designed to detect breast abnormalities before they become clinically apparent. Mammography remains an important tool for the early detection of breast cancer and can identify masses, calcifications, and other suspicious changes.
Screening recommendations vary among organizations and should be individualized according to the patient’s age and breast cancer risk. Patients at elevated risk may require an earlier or more intensive screening strategy.
Diagnostic breast imaging is used when a patient has a symptom or when a screening examination identifies an abnormality.
Common reasons for diagnostic evaluation include:
A new palpable breast mass
Focal or persistent breast pain
Nipple discharge
Nipple or skin changes
An abnormal screening mammogram
A new clinical breast finding
Ultrasound is particularly useful for evaluating a palpable abnormality and distinguishing fluid-filled cysts from solid masses. Depending on the patient’s age and clinical circumstances, diagnostic mammography and ultrasound may be used together.
Breast magnetic resonance imaging (MRI) is not a routine screening test for everyone. It is generally reserved for selected patients, particularly those with a substantially increased risk of breast cancer or specific diagnostic or treatment-planning indications.
Breast MRI may be considered for individuals with:
A high calculated lifetime risk of breast cancer
Certain pathogenic genetic variants, including BRCA1 or BRCA2
A strong hereditary or family history
Selected situations involving an already diagnosed breast cancer
Certain unresolved findings after conventional imaging
MRI is highly sensitive, but it can also identify abnormalities that require additional evaluation. Therefore, it is generally used in combination with, rather than as a universal replacement for, mammography.
When imaging identifies a suspicious breast lesion, tissue sampling may be necessary to establish a definitive diagnosis. Image-guided core needle biopsy is commonly used because it obtains tissue samples that can be examined by a pathologist.
Biopsy results help determine whether a lesion is benign, atypical, in situ, or invasive and can guide subsequent treatment or surveillance.
The Breast Imaging Reporting and Data System (BI-RADS), developed by the American College of Radiology, provides a standardized approach to reporting breast imaging findings.
BI-RADS categories help clinicians understand the level of concern associated with an imaging finding and determine the appropriate next step.
BI-RADS 0: Incomplete; additional imaging or comparison with previous studies is needed.
BI-RADS 1: Negative; no abnormal imaging finding is identified.
BI-RADS 2: Benign finding; routine screening is generally appropriate.
BI-RADS 3: Probably benign; short-interval imaging follow-up is generally recommended.
BI-RADS 4: Suspicious abnormality; tissue diagnosis should be considered.
4A: Low suspicion for malignancy
4B: Moderate suspicion
4C: High suspicion
BI-RADS 5: Highly suggestive of malignancy; appropriate action, including tissue diagnosis, is strongly recommended.
BI-RADS 6: Known biopsy-proven malignancy.
Understanding BI-RADS helps healthcare professionals translate radiology reports into appropriate clinical follow-up. A BI-RADS category is an imaging assessment and does not by itself replace pathological diagnosis when biopsy is indicated.
Many breast complaints evaluated in primary care are benign. Benign breast conditions may produce palpable masses, pain, tenderness, nipple discharge, or other changes that can sometimes resemble more concerning findings.
Features that may be associated with benign breast conditions include masses that are smooth and mobile, symptoms that fluctuate with the menstrual cycle, and changes that correspond with hormonal variations. However, physical characteristics alone cannot reliably exclude malignancy.
Nipple discharge should be assessed carefully. Clinicians should ask about pregnancy, breastfeeding, medications, hormonal conditions, and whether the discharge is spontaneous or occurs only with manipulation.
Discharge that is bloody, clear and spontaneous, unilateral, or associated with a palpable mass generally warrants further evaluation.
Fibroadenomas are common benign breast tumors, particularly among adolescents and younger adults. They consist of both stromal and glandular tissue and are generally noncancerous.
A typical fibroadenoma may feel:
Smooth
Firm or rubbery
Well circumscribed
Mobile
Usually painless
Some fibroadenomas can enlarge in response to hormonal changes, including during pregnancy.
Ultrasound is commonly used to evaluate a breast mass in younger patients, while the choice of imaging depends on age, clinical findings, and individual risk factors. Some lesions require biopsy when imaging cannot establish a sufficiently confident benign diagnosis.
Breast cysts are fluid-filled structures that are common, particularly during the reproductive and perimenopausal years. They may be discovered incidentally or present as palpable breast lumps.
Breast cysts may be:
Smooth
Mobile
Fluid-filled
Tender, particularly before menstruation
Associated with cyclical breast discomfort
Ultrasound can help determine whether a palpable lesion is cystic or solid.
Management depends on the cyst’s appearance, symptoms, and imaging characteristics. Simple cysts that are asymptomatic and have benign imaging features may require no intervention, whereas symptomatic or complex lesions may require aspiration, follow-up imaging, or tissue sampling.
Phyllodes tumors are uncommon fibroepithelial breast tumors that can be benign, borderline, or malignant. They may resemble fibroadenomas clinically and radiologically, making accurate diagnosis important.
A phyllodes tumor may present as a:
Firm or mobile breast mass
Rapidly enlarging lesion
Large palpable abnormality
Usually painless mass
Because some phyllodes tumors can grow rapidly and recur locally, suspicious lesions generally require tissue diagnosis and surgical management. The treatment approach depends on tumor characteristics and pathology.
Lactational mastitis is an inflammatory breast condition that can occur during breastfeeding. Modern approaches emphasize effective milk removal and management of inflammation while recognizing that bacterial infection is not present in every case.
Symptoms may develop suddenly and can include localized breast pain, swelling, redness, warmth, and systemic symptoms.
Common findings include:
Localized breast pain
Swelling
Erythema
Tenderness
Breast firmness or induration
Fever
Chills or fatigue
Flu-like symptoms
Initial management commonly focuses on reducing inflammation and supporting continued breastfeeding or physiologic milk removal.
Supportive measures may include:
Continuing breastfeeding according to the infant’s needs
Avoiding excessive breast pumping or aggressive massage
Rest and adequate hydration
Supportive breast support
Cold compresses for inflammation
Nonsteroidal anti-inflammatory drugs when appropriate
Antibiotics may be appropriate when bacterial mastitis is suspected, particularly when symptoms are severe, worsening, or persistent despite conservative management.
Antibiotic selection should consider local resistance patterns, allergies, previous antibiotic exposure, and the likelihood of Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA).
Because antibiotic recommendations and treatment duration can vary, clinicians should follow current evidence-based guidelines rather than relying on a single standardized regimen for every patient.
A breast abscess is a localized collection of pus that can develop following mastitis or another breast infection. Patients may continue to experience symptoms despite appropriate initial treatment.
Possible findings include:
Persistent localized breast pain
A tender or fluctuant mass
Persistent fever
Increasing redness or swelling
Failure to improve with appropriate treatment
Ultrasound can help identify a fluid collection. Treatment often involves drainage, which may be performed using needle aspiration or another drainage procedure depending on the size and characteristics of the abscess.
Antibiotics may also be required, particularly when systemic infection or surrounding cellulitis is present.
Breast cancer does not always cause pain. A new breast or nipple change may be the first indication of disease, which is why persistent or unexplained changes should be evaluated.
Potential warning signs include:
A new breast or underarm lump
Skin dimpling
Thickening or swelling of part of the breast
Peau d’orange, or an orange-peel appearance
New nipple inversion
Bloody or otherwise abnormal nipple discharge
Persistent changes in breast shape or size
A firm or fixed mass
Persistent focal breast pain or other unexplained changes
Breast pain alone is often not a sign of cancer, particularly when it is diffuse or cyclical. However, persistent focal or unexplained pain should be evaluated in the context of the patient’s history and examination.
Breast cancer risk is influenced by a combination of age, genetics, reproductive history, hormonal exposure, lifestyle factors, and personal or family history.
Important risk factors include:
Increasing age
Personal history of breast cancer
Family history of breast or ovarian cancer
Certain inherited genetic variants, including BRCA1 and BRCA2
Dense breast tissue
Certain reproductive and hormonal factors
Alcohol consumption
Previous chest radiation at a young age
Some forms of hormone therapy
Having a risk factor does not mean that a person will develop breast cancer. Conversely, people without recognized risk factors can still develop the disease.
Some modifiable factors are associated with lower breast cancer risk, including:
Maintaining a healthy body weight
Engaging in regular physical activity
Limiting alcohol consumption
Breastfeeding when possible
Following appropriate screening recommendations
Risk-reduction strategies should be individualized, particularly for people with a strong family history or hereditary cancer risk.
Breast cancer staging describes the extent of disease and helps healthcare teams select an appropriate treatment strategy.
The traditional TNM system evaluates:
T: Characteristics and size or extent of the primary tumor
N: Involvement of regional lymph nodes
M: Presence or absence of distant metastasis
Modern breast cancer staging can incorporate additional information, including tumor grade and biomarkers such as estrogen receptor, progesterone receptor, and HER2 status.
Staging may therefore involve clinical examination, diagnostic imaging, biopsy results, surgical pathology, lymph node evaluation, and biomarker testing.
Early evaluation does not mean that every breast lump is cancerous. In fact, many breast abnormalities are benign. The purpose of clinical assessment is to identify the relatively small number of findings that require additional investigation while avoiding unnecessary procedures for clearly benign conditions.
For nurses and primary care providers, an effective approach combines careful history taking, systematic examination, risk assessment, appropriate imaging, accurate documentation, and timely referral.
Patients should also understand that screening recommendations are not identical for everyone. Age, personal risk, family history, genetic factors, symptoms, and previous imaging can all influence the recommended approach.
Breast assessment requires a structured approach because benign and malignant conditions can sometimes present with similar findings. A mobile, smooth mass may be benign, but physical examination alone cannot definitively establish the diagnosis.
The most important clinical principles are to:
Evaluate new or persistent breast changes.
Distinguish screening from diagnostic imaging.
Use ultrasound, mammography, MRI, and biopsy according to the clinical situation.
Understand BI-RADS categories and their recommended follow-up.
Recognize common benign conditions such as fibroadenomas, cysts, mastitis, and phyllodes tumors.
Identify breast cancer warning signs.
Assess individual breast cancer risk.
Coordinate appropriate follow-up and referral.
Educate patients about breast health and evidence-based screening.
American Cancer Society. (2025). Breast cancer signs and symptoms. https://www.cancer.org/cancer/types/breast-cancer/detection-diagnosis-staging/signs-symptoms.html
American College of Radiology. (2024). ACR BI-RADS® Atlas: Breast imaging reporting and data system. https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/Bi-Rads
American College of Radiology. (2024). ACR Appropriateness Criteria® palpable breast masses. https://acsearch.acr.org/docs/69495/Narrative/
American College of Radiology. (2023). ACR Appropriateness Criteria® breast cancer screening. https://acsearch.acr.org/docs/70910/Narrative/
Centers for Disease Control and Prevention. (2024). Breast cancer statistics. https://www.cdc.gov/breast-cancer/data-research/
National Cancer Institute. (2024). Breast cancer treatment (PDQ®)—Patient version. https://www.cancer.gov/types/breast/patient/breast-treatment-pdq
National Cancer Institute. (2024). Breast cancer risk factors. https://www.cancer.gov/types/breast/risk-fact-sheet
World Health Organization. (2024). Breast cancer. https://www.who.int/news-room/fact-sheets/detail/breast-cancer
